Clinical Trials Logo

Filter by:
NCT ID: NCT01700244 Active, not recruiting - Clinical trials for Normal Sinus Rhythm With 2 or 3° AV or BBB Block

Evaluation of a New Cardiac Pacemaker

Start date: December 2012
Phase: N/A
Study type: Interventional

An evaluation of a safety and performance of a new cardiac pacemaker

NCT ID: NCT01697358 Active, not recruiting - Back Pain Clinical Trials

Spinal Cord Stimulation for Predominant Low Back Pain

PROMISE
Start date: January 2013
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare the effectiveness of spinal cord stimulation (SCS) using the Medtronic Specify® 5-6-5 multicolumn surgical lead plus optimal medical management (OMM) versus OMM alone in patients suffering from predominant low back pain due to failed back surgery syndrome (FBSS).

NCT ID: NCT01667536 Active, not recruiting - Prostate Cancer Clinical Trials

A Phase 2 Diagnostic Imaging Study With 99mTc-MIP-1404 in Men With High-Risk Prostate Cancer Scheduled for Radical Prostatectomy (RP) and Extended Pelvic Lymph Node Dissection (EPLND) Compared to Histopathology

Start date: August 2012
Phase: Phase 2
Study type: Interventional

This is a single arm, open label study of approximately 100 high-risk prostate cancer patients scheduled for prostatectomy and extended pelvic lymph node dissection. Patients receive a single IV dose of 99mTc-MIP-1404 (study drug) followed by SPECT/CT scan 3-6 hours after injection. As standard of care, patients will undergo prostatectomy and extended pelvic lymph node dissection (EPLND) within three weeks of study drug dosing. 99mTc-MIP-1404 image data will be evaluated for visible uptake and compared with histopathology.

NCT ID: NCT01658930 Active, not recruiting - Cervical Cancer Clinical Trials

Radical Versus Simple Hysterectomy and Pelvic Node Dissection With Low-risk Early Stage Cervical Cancer

SHAPE
Start date: December 10, 2012
Phase: N/A
Study type: Interventional

The reason this study is being done is to see if a simple hysterectomy is as good as a radical hysterectomy in preventing cancer of the cervix from returning, and whether, because less tissue surrounding the uterus is removed during surgery, there are fewer side-effects after the surgery and in the long-term.

NCT ID: NCT01646632 Active, not recruiting - Physical Disability Clinical Trials

Exercise Intervention in Institutionalized Elderly People

BENENFIT
Start date: October 2009
Phase: Phase 2
Study type: Interventional

Questions: Does an evidence-based exercise program increase activities of daily living and physical fitness in institutionalized older adults? Does this program decrease the care dependency of institutionalized older adults? Design: A randomized control trial using group-based exercise was performed in 14 assisted-living facilities for the elderly (>70 years old). Outcome measures: Outcome measures were performance on ADL, physical fitness, and care dependency measures. The exercise program comprised group-based progressive resistance training, balance training, and functional training. The control intervention comprised social group meetings.

NCT ID: NCT01646034 Active, not recruiting - Breast Cancer Clinical Trials

High Dose Chemotherapy in Oligo-metastatic Homologous Recombination Deficient Breast Cancer

Oligo
Start date: September 2014
Phase: Phase 3
Study type: Interventional

This study investigates the effect of high-dose alkylating chemotherapy compared with standard chemotherapy as part of a multimodality treatment approach in patients with oligo-metastatic breast cancer harboring homologous recombination deficiency.

NCT ID: NCT01644786 Active, not recruiting - Clinical trials for Head and Neck Squamous Cell Carcinoma

The Head and Neck Tumor Biobank

Start date: August 2012
Phase:
Study type: Observational

The purpose of the biobank is to enable future genomic based research on this Head and Neck Cancer patient population. The investigators will try to identify tumor factors that will predict cancer-related outcome in order to improve the outcome prediction after treatment in a patient-individualized manner.

NCT ID: NCT01643330 Active, not recruiting - Heart Failure Clinical Trials

A Study of Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure

CUPID-2b
Start date: July 2012
Phase: Phase 2
Study type: Interventional

The purpose of this trial is to assess whether MYDICAR can reduce the frequency and/or delay heart failure related hospitalizations in persons with advanced heart failure when added to their maximal and optimized therapy.

NCT ID: NCT01640678 Active, not recruiting - Piebaldism Clinical Trials

Autologous Cell Suspension Grafting Using ReCell in Vitiligo and Piebaldism Patients

Start date: June 2012
Phase: Phase 4
Study type: Interventional

Autologous epidermal cell suspension grafting is an effective method of surgical treatment in vitiligo, which is suitable for treating larger areas with better cosmetic results as compared to other grafting methods. The ReCell Autologous Cell Harvesting Device (Avita Medical Europe Limited, Cambridge, UK) is an autologous cell harvesting device which, compared to other forms of autologous epidermal cell suspension grafting, is easier in use showing similar results. Furthermore, the ReCell device needs no laboratory facilities. Therefore, it is promising for patients with large vitiligo and piebaldism lesions. Objectives: Primary: to asses the efficacy and safety of autologous epidermal cell suspension grafting with the ReCell device after CO2 laser abrasion compared to CO2 laser abrasion alone and no treatment, in patients with piebaldism and stable vitiligo. Secondary: to assess the practical aspects and patients satisfaction of autologous epidermal cell suspension grafting with the ReCell device. Study design: Prospective observer blinded randomized controlled pilot study. Study population: 10 patients ≥ 18 years with stable segmental vitiligo or piebaldism who are under treatment at the Netherlands Institute for Pigment Disorders (NIPD) at the Academic Medical Centre University of Amsterdam. Methods: Three depigmented regions on the trunk or proximal extremities will be randomly allocated to; CO2 laser abrasion + ReCell autologous cell suspension grafting, or CO2 laser abrasion, or no treatment. After the transplantation, UV-treatment according to the standard treatment protocol of the NIPD will be started on all sites and continued for 3 months. Three and six months after grafting, the percentage of repigmentation of the lesions will be assessed.

NCT ID: NCT01638780 Active, not recruiting - Type 2 Diabetes Clinical Trials

Resveratrol and Type 2 Diabetes

Start date: May 2012
Phase: N/A
Study type: Interventional

The main objective of the study is to investigate if resveratrol supplementation can improve overall and muscle-specific insulin sensitivity in type 2 diabetic patients. As a secondary objective the investigators want to investigate whether the improved insulin sensitivity can be attributed to improved muscle mitochondrial oxidative capacity and a reduced intrahepatic and cardiac lipid content.